BioHealth Innovation, Inc.’s Post

The Weekly BHI E-Newsletter is live with stories and news on: 🎙️ Life Sciences Real Estate and Talent Trends: Insights from Matt Gardner of CBRE about the latest in life sciences trends. on the BioTalk Podcast. 🚀 ATTENTION START-UPS: Apply to Compete in the 9th Annual Crab Trap Competition - Applications are being accepted now! 📰 Forbes: Meet The New Biotech Billionaire Putting Pig Hearts In Humans - Martine Rothblatt becomes a billionaire with her firm, United Therapeutics Corporation, and groundbreaking biotech advancements. 🏥 Children's National Hospital Innovational District: Closing the ‘Valley of Death’—Experts are addressing high costs and regulatory barriers to pediatric therapies. 🧪 Gaithersburg's Shuttle Pharmaceuticals, Inc. Shows Promise Against Breast Cancer - A new HDAC inhibitor demonstrates substantial growth inhibition of breast cancer cells. 🏠 Embracing Home as a Health Care Hub: FDA's Virtual Stakeholder Listening Session - On July 25 exploring integrating home environments into healthcare to enhance patient care. 🔬 Discover Innovation at the 2024 National Cancer Institute (NCI) Technology Showcase - This event on September 4 will present cutting-edge technologies ready for commercialization. 💡 Capra Biosciences Lands $7.5 Million Project Agreement - The BioMaP-Consortium will use AI for scalable manufacturing of pharmaceutical ingredients. 🔬 Danaher Corporation Announces Two New Centers of Innovation - new labs to advance Companion and Complementary Diagnostics. 💊FDA Rare Disease Innovation Hub to Enhance Outcomes - new hub focuses on improving treatments and patient engagement for rare diseases. 💵 WBJ: D.C. Maternal Mental Health Startup Seven Starling Raises $11M to expand virtual care services for maternal mental health. https://lnkd.in/ghKRjj7h

The latest BHI E-Newsletter is live. This we have stories including: 🗓️ Save the Dates: BioHealth Capital Region Week in Autumn 2024 promises to bring together industry leaders, investors, and innovators across biopharma and healthcare sectors. Registration and application sites will be going live soon. 🧪 BioHealth Innovation, Inc. is seeking an Entry-Level Life Sciences Business Strategist, ideal for recent PhD graduates passionate about blending scientific expertise with business acumen. 🏗️ MCB Real Estate announces plans for VIVA White Oak, a mixed-use development in Montgomery County with a focus on life sciences and BioHealth, adjacent to key institutions like the FDA and White Oak Medical Center. 💊 Vanda Pharmaceuticals reports positive results from a Phase III study of Tradipitant in motion sickness, confirming its effectiveness in preventing vomiting associated with motion sickness. 🔬 The Maryland Stem Cell Research Commission awards over $15.4 million to 48 scientists to accelerate stem cell treatments and technologies, supporting research across various institutions and companies in Maryland. 🩺 Amplexd Therapeutics advances its non-invasive treatments for HPV-induced Cervical Intraepithelial Neoplasia (CIN), securing $2 million for product development ahead of Phase 1/2 clinical trials. 💰 Sands Capital closes Pulse Fund III at $555 million, increasing total Pulse strategy capital commitments to $1.3 billion, supporting private companies in transforming disease diagnosis and treatment. all this and more. Visit https://lnkd.in/euZ42fpC

The Weekly BHI E-Newsletter is live. This week we have news including: 🩺 Linshom Medical, Inc.: Chosen as a finalist for the Medical Threat Challenge at TechConnect World Innovation Conference. 🚀 HyperSpectral: Secures $8.5M Series A funding for AI-powered spectral intelligence software. 🔬 I-Mab Biopharma Collaboration: Teams up with Bristol Myers Squibb to evaluate treatment for advanced gastric and esophageal cancers. 💡 BioHealth Innovation: Offers assistance in securing federal funding for innovators through SBIR and STTR programs. 🧬 IGC PHARMA Study: Publishes research on genetic polymorphisms' impact on Alzheimer's treatment effectiveness. 🩸 Barinthus Biotherapeutics: Presents positive trial data for VTP-300 in chronic hepatitis B treatment. 🔬 REPROCELL USA Funding: Receives funding for stem cell research from Maryland Stem Cell Research Fund (MSCRF). 💉 US FDA Approval: Expands age indication for GSK’s Arexvy RSV vaccine for adults aged 50-59 at increased risk. https://lnkd.in/gaMAp2Mp

The Latest BHI Weekly E-Newsletter is live with stories including: ⏳ Two Weeks Left! Apply for the 9th Annual Crab Trap Competition Before August 30th - Submit your application for the September 18th competition at USP, Rockville, MD. 🌍 Bringing the BioHealth Capital Region to South Africa: BioTalk features insights from Johann de Bruyn, CA(SA), MBA, Ethan Hunter, and Dr. Carla Eksteen. 🗳️ Association of University Research Parks (AURP) partners in support of the 10th Annual BioHealth Capital Region Forum 👩🔬 Women In Bio - Engage. Educate. Empower. (WIB) to Participate in the 10th Annual BioHealth Capital Region Forum 💵 Biden-Harris Administration Announces $150 Million from Advanced Research Projects Agency for Health (ARPA-H) for Cancer Moonshot Goals - New funding to advance cancer research and health outcomes. 📈 TEDCO’s Maryland Innovation Initiative Invests $2.1M - Seven companies receive funding to advance Maryland-based innovations. 🧬 AstraZeneca’s Imfinzi Approved in the US for NSCLC - New approval for treating resectable non-small cell lung cancer before and after surgery. 🏗️ United Therapeutics Corporation to Build Medical Transplant Center in Minnesota - New facility for gene-edited organ research to support clinical trials. 📢 TEDCO Promotes Kim Mozingo to Vice President, Federal Programs to lead federal programs aimed at transforming scientific research into economic growth. https://lnkd.in/eVi6Wfmf

The weekly BHI E-Newsletter is live with.... 🌟 Leadership and Innovation Take Center Stage: BioHealth Capital Region Week 2024 features keynotes and discussions with industry leaders and governors. 🎤 Maryland Gov. Wes Moore Addresses BioHealth Forum: The governor delivers remarks at the 10th Annual BioHealth Capital Region Forum. 🏆 Virginia Governor Glenn Youngkin Honored: Recognized as BIO’s Governor of the Year during the opening day of the BioHealth Capital Region Forum. 🚀 BioHealth Innovation and Georgetown University Collaborate: A strategic partnership aims to accelerate the commercialization of innovative research. 💰 VerImmune Completes $4.5 Million Pre-Series A Financing: The biotechnology company strengthens its board with two new executives. 🏥 Children's National Hospital Receives $35 Million Gift: Funding from the UAE government will support prenatal and neonatal care advancements. 💉 Emergent BioSolutions Secures $67.4 Million Contract: Additional TEMBEXA® treatment courses will support national preparedness efforts. 🧬 miRecule, Inc. Showcases RNA Therapies at RESI Boston: The biotechnology company highlights its innovative programs at a major industry event. 💵 NIH Awards Sonavex $2 Million Grant: Funding will support clinical trials for the EchoGuide device aimed at improving dialysis patient care. 🧪 Georgiamune Inc. Doses First Participant in Phase 1 Trial: GIM-407 aims to develop treatments for autoimmune diseases as it enters human trials. 🔬 Altimmune, Inc. Completes Enrollment in Phase 2b Trial: The company’s pemvidutide study evaluates treatments for metabolic dysfunction-associated steatohepatitis (MASH). 🌍 BioBridges Launches Dedicated MedTech Division: New services aim to support companies navigating transformation in the MedTech industry. https://lnkd.in/eSrrgFZe

The Post-BioHealth Capital Region Week BHI E-Newsletter is live! This week we have stories including: 🌟 Leadership and Innovation at BioHealth Capital Region Week: Industry leaders, including Maryland Gov. Wes Moore and Virginia Governor Glenn Youngkin gather for impactful keynotes, panels, discussions and networking opportunities. 🎉 Linshom Medical, Inc. Wins Crab Trap Competition: The TEDCO-backed company secures the title with its FDA-cleared wearable respiratory monitoring device. 🏅 Virginia Governor Recognized: Glenn Youngkin receives BIO’s 2024 Governor of the Year Award for his leadership in strengthening the state's biotechnology sector. 🌍 Immobazyme Competes in Crab Trap: The South African biotech company presents its innovative solutions for diabetic foot ulcers at the competition. h/t TASK 🚀 Advanced Research Projects Agency for Health (ARPA-H) Launches Emerging Health Innovators Initiative: This program aims to increase access to government research funding for early career researchers. 🏥 Children's National Hospital Innovation District Partners with BARDA: A new hub will focus on developing solutions for pediatric health emergencies. 🔍 USP Seeks Expert Volunteers: The US Pharmacopeia calls for professionals to contribute to its mission of ensuring the quality of healthcare products. 💰 TEDCO Invests in CarrTech Corporation, a life sciences company working to support patients and healthcare providers. The Builder Fund is part of TEDCO’s Social Impact Funds, an umbrella of funds designed to support underserved founders and communities. 📈 NIH Establishes Pandemic Preparedness Network: The agency plans up to $100 million annually for research on new treatments and vaccines. 💉 AstraZeneca’s FluMist Approved for Self-Administration: The needle-free nasal spray vaccine is now available for self-administration in eligible age groups. 💻 Astellas Pharma Announces FDA Listing of DIGITIVA™: The digital health solution for heart failure management is classified as a Class I Software as a Medical Device. 📅 Activation Capital Launches Start-the-Journey Program: The new pre-accelerator supports early-stage biotech entrepreneurs with essential tools and knowledge. 🌱 Maryland Stem Cell Research Fund (MSCRF) Awards Grants: Approximately $4.5 million is allocated to advance stem cell research and innovation. all this and more by visiting https://lnkd.in/g2Tha_83

Good Morning - The latest BioHealth Innovation, Inc. E-Newsletter is Live! This week learn about: 🌟 Building Baltimore's Future: Kory Bailey and UpSurge Vision on BioTalk - Kory Bailey, Chief Ecosystem Officer of UpSurge Baltimore, shares insights into fostering equitable economic growth and innovation in Baltimore's tech ecosystem, pioneering a new model for American innovation. 💼 TEDCO Invests in Innate Technologies, Inc. -TEDCO invests $500,000 in Innate Technologies, Inc., a Maryland-based digital manufacturing solutions provider, to revolutionize manufacturing through data collaboration. 🧬 AMPEL BioSolutions' Lupus Test Launches for Predicting Flares & Drug Targets -AMPEL BioSolutions launches LuGENE®, a blood test utilizing predictive AI to forecast Lupus patient flares and drug targets, revolutionizing Lupus management. 🏥 Built in Baltimore: CoapTech, Inc. Announces Market Launch of Second -Generation Magnetic Balloon Catheter for PUMA-G System CoapTech, Inc. launches its second-generation magnetic balloon catheter, a key component of the PUMA-G System™ for ultrasound-guided placement of gastrostomy tubes, enabling minimally-invasive surgery. 💉 Germantown's Precigen biotech expands manufacturing capacity ahead of potential product launch - Precigen Inc. expands manufacturing capacity to advance an immunotherapy for recurrent respiratory papillomatosis, aiming for potential market launch in 2025. 🏢 BioFactura, Inc. Expands presence at Riverside Tech Park in Frederick, Maryland - BioFactura, Inc. expands its presence in Frederick, Maryland, consolidating operations and anticipating employment growth to over 50 professionals. 🧬 CEL-SCI Corporation’s LEAPS Vaccine Offers New Paradigm to Treat Rheumatoid Arthritis: Published in Frontiers in Immunology - CEL-SCI Corporation's LEAPS technology shows promise in treating rheumatoid arthritis by rebalancing the inflammatory response without compromising immune defense mechanisms. 💡 Clasp Therapeutics Launches With $150 Million to Pioneer Precision Immuno-Oncology - Clasp Therapeutics launches with $150 million in financing to develop modular T cell engagers tailored to each patient's immune system for precision immuno-oncology. Read more by visiting https://lnkd.in/ezFwv89k

Good Morning, a new BHI E-Newsletter is live with stories from across the BioHealth Capital Region including: 🤝 Novavax and Sanofi enter a co-exclusive licensing agreement to co-commercialize Novavax's COVID-19 vaccine and develop novel COVID-19-influenza combination vaccines, with Sanofi taking a minority equity investment in Novavax. 🏆 NextStep Robotics wins the $20,000 Grand Prize in the Pitch Dingman Competition and appoints new board members to support its stroke rehabilitation technologies. 👩⚕️ Linshom Medical, Inc. is chosen by the NIH to represent its SBIR grant portfolio at the Angel Capital Association annual meeting, recognizing its innovative medical device solutions. 🏅 Welldoc is named "Best Overall Digital Health Company" for the second consecutive year in the MedTech Breakthrough Awards, highlighting its AI-powered platform for cardiometabolic health. 🔬 Stem cell research advances showcased at the Maryland Stem Cell and Regenerative Medicine Technology Showcase, highlighting Maryland's leadership in regenerative medicine. 🩺 Kite Pharma and Arcellx announce operational updates on their anitocabtagene autoleucel (anito-cel) multiple myeloma program, including the design of a Phase 3 clinical trial, iMMagine-3. 🧠 Danaher Corporation launches a collaboration with The Johns Hopkins University to improve neurological diagnosis, leveraging technology to develop new methods for diagnosing mild traumatic brain injury. ⚕️ Caring Cross and ImmunoAdoptive Cell Therapy (ImmunoACT) agree to develop and commercialize a novel TriCAR-T cell immunotherapy for leukemia and lymphoma, aiming to improve outcomes for patients. Read all this and more by visiting https://lnkd.in/ehAE-xd5

My heartfelt gratitude to the 51 Pharma and Biotech companies, as well as the National Institutes of Health (NIH), for engaging in insightful discussions during the One-on-One Partnering Program at BIO2024. Their keen interest in our Multiomics and Biomimetic Digital Twin Ecosystem analysis is truly inspiring, underscoring the importance of collaborative innovation in the healthcare industry. Through the publication of peer-reviewed papers, we have showcased the transformative impact of our work: - Enhanced pathophysiology understanding of diseases - Commencement of reclassification of variants of unknown clinical significance (VUSs) - Potential reduction in drug development time and costs by approximately 25-35% A significant milestone in our journey is the establishment of a partnership with the NIH for groundbreaking research on rare diseases. Looking forward to continued collaboration and advancements in healthcare that benefit patients worldwide. #Biotech #Pharma #HealthcareInnovation #Collaboration #Research #BIO2024

How to fast-track clinical development and unlock the full potential of microbiome-based therapies. Our expert, Jelle Klein, will share his insights at Pharmabiotics Conference & Partnering . Olawale Salami, our head of project management and feasibility for health science, will also be at the event and would be delighted to connect with you there. Do you have burning questions about this hot topic? Drop a message in this post, and let's spark the conversation online! #Pharmabiotics #Microbiome #ClinicalDevelopment #HealthScience